Compare CIGL & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CIGL | NAUT |
|---|---|---|
| Founded | 1997 | 2016 |
| Country | Singapore | United States |
| Employees | 134 | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 417.7M | 383.5M |
| IPO Year | N/A | 2020 |
| Metric | CIGL | NAUT |
|---|---|---|
| Price | $1.99 | $2.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 68.1K | ★ 451.3K |
| Earning Date | 05-15-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.07 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $992.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.40 | $0.62 |
| 52 Week High | $25.00 | $4.31 |
| Indicator | CIGL | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 56.54 | 41.03 |
| Support Level | $1.55 | $2.22 |
| Resistance Level | $2.28 | $2.54 |
| Average True Range (ATR) | 0.16 | 0.18 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 69.49 | 12.50 |
Concorde International Group Ltd is an integrated security services provider that combines physical manpower and technology to deliver effective security solutions. The company offers a range of services to enhance security and safety: (1) i-Guarding Services; (2) Man-Guarding Services; and (3) Consultancy and Training Services. Its i-Guarding Services leverages technology to increase efficiency, with a mobile platform and cluster aggregation model of a higher skillset workforce. It has two operating segments, which are (i) security services; and (ii) training school. Key revenue is generated from Security Services.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.